| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 862270-48-2 | 1-[(1R)-1-(4-Fluorophenyl)ethyl]piperazine | C12H17FN2 |
| 862270-90-4 | 3-Methoxy-1,2-benzenediamine dihydrochloride;3-Methoxybenzene-1,2-diamine dihydrochloride | C7H10N2O.2(HCl) |
| 862270-94-8 | 5-Hydroxy-1,4-dihydro-2,3-quinoxalinedione | C8H6N2O3 |
| 862273-27-6 | (1R,2S)-Methyl 1-amino-2-vinylcyclopropanecarboxylate 4-methylbenzenesulfonate | C7H11NO2.C7H8O3S |
| 862274-39-3 | 6-Fluoro-1H-indazol-3-ol | C7H5FN2O |
| 862368-61-4 | 5-tert-butyl-2-(2-methoxyphenyl)pyrazol-3-amine | C14H19N3O |
| 862372-66-5 | 3-Amino-1-Boc-pyrrolidine-3-carboxylic acid;3-Amino-1-(tert-butoxycarbonyl)pyrrolidine-3-carboxylic acid; 3-Amino-pyrrolidine-1,3-dicarboxylic acid 1-tert-butyl ester | C10H18N2O4 |
| 862372-92-7 | (S)-1-Boc-3-Aminopiperidine-3-carboxylic acid;(S)-3-Amino-1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid; (S)-3-Amino-piperidine-1,3-dicarboxylic acid 1-tert-butyl ester | C11H20N2O4 |
| 862401-49-8 | (1R,3R)-3-Aminocyclohexanecarboxylic acid hydrochloride (1:1) | C7H14ClNO2 |
| 862416-37-3 | 3,3-Difluoro-1-(phenylmethyl)pyrrolidine hydrochloride | C11H13F2N.HCl |
| 862466-16-8 | 2-Methyl-2-propanyl [1-(4-fluorophenyl)-3-hydroxypropyl]carbamate | C14H20FNO3 |
| 862499-50-1 | (1S,4S,8S)-5-Benzyl-2-isobutyl-8-methoxy-1,8-dimethylbicyclo[2.2.2]octa-2,5-diene | C22H30O |
| 862500-24-1 | 2-(4-Morpholinylsulfonyl)benzaldehyde | C11H13NO4S |
| 862505-00-8 | 5-(2-(1,1-Dimethylethyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-(2,2-dimethylpropyl)-3H-imidazo(4,5-b)pyridin-2-amine | C24H29FN6 |
| 862507-23-1 | 5-(2-(tert-Butyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl)-3-(2,2-dimethylpropyl)-3H-imidazo(4,5-b)pyridin-2-amine methanesulfonate | C24H29FN6.2(CH4O3S) |
| 862508-03-0 | (5-Fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl)carbamic acid pentyl ester | C10H14FN3O3 |
| 862539-91-1 | 2-Methyl-4-fluorobenzyl bromide;1-(Bromomethyl)-4-fluoro-2-methylbenzene | C8H8BrF |
| 862574-88-7 | 1-(2,2-Difluorobenzodioxol-5-yl)cyclopropanecarboxylic acid | C11H8F2O4 |
| 862574-89-8 | 1-(1,3-Benzodioxol-5-yl)cyclopropanecarboxylic acid | C11H10O4 |
| 862578-42-5 | 4-(3,4-Dimethoxyphenyl)-2,2-dimethyl-4-oxobutanoic acid | C14H18O5 |
| 862588-62-3 | 3-(4-Chlorophenyl)-1-methyl-1H-pyrazol-5-ol | C10H9ClN2O |
| 862599-47-1 | Ethyl 2-chloro-oxazole-5-carboxylate;2-Chlorooxazole-5-carboxylic acid ethyl ester; Ethyl 2-chloro-1,3-oxazole-5-carboxylate | C6H6ClNO3 |
| 862686-09-7 | 1-[4-(4-Amino-2-Methylphenyl)-1-Piperazinyl]-Ethanone | |
| 862723-42-0 | 1H-Indazole-5-boronic acid pinacol ester;5-(4,4,5,5-Tetramethyl-(1,3,2)dioxaborolan-2-yl)-1H-indazole; Indazole-5-boronic acid pinacol ester | C13H17BN2O2 |
| 862731-66-6 | 1-Octyl-3-methylimidazolium bis(2,2,2-trifluoroacetyl)imide;1-Methyl-3-octyl-1H-imidazolium salt with 2,2,2-trifluoro-N-(trifluoroacetyl)acetamide | C12H23N2.C4F6NO2 |
| 862772-11-0 | Cyclo(L-arginylglycyl-L-alpha-aspartyl-D-phenylalanyl-L-cysteinyl) | C24H34N8O7S |
| 862776-43-0 | 1-(2-Chloro-4-nitrophenyl)-1H-imidazole | C9H6ClN3O2 |
| 862812-98-4 | 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(methylsulfonyl)benzyl]oxy}-2-thiophenecarbonitrile | C22H19N3O5S2 |
| 862847-75-4 | 7-Bromo-9,9,9',9'-tetraethyl-2,2'-bifluorene | C34H33Br |
| 862874-75-7 | 2-Methyl-2-propanyl 3-(4-aminophenoxy)-1-pyrrolidinecarboxylate | C15H22N2O3 |
| 862894-96-0 | Bortezomib Impurity 4;(S)-N-(1-(3-Methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide | C19H22N4O3 |
| 862895-00-9 | Bortezomib Impurity 11;N-((1S)-2-(((1E)-3-Methyl-1-buten-1-yl)amino)-2-oxo-1-(phenylmethyl)ethyl)-2-pyrazinecarboxamide | C19H22N4O2 |
| 862901-87-9 | (alphaS)-alpha-((1,1'-Biphenyl)-4-yloxy)benzenepropanoic acid;LT 175 | C21H18O3 |
| 862996-27-8 | (2R,4S)-4-Hydroxy-1,2-pyrrolidinedicarboxylic acid bis(1,1-dimethylethyl) ester | C14H25NO5 |
| 863015-82-1 | 1,3,4-Oxathiazinane 3,3-dioxide | C3H7NO3S |
| 863028-98-2 | 4-(Methylamino)-2-(methylsulfanyl)-5-pyrimidinecarboxylic acid | C7H9N3O2S |
| 863029-89-4 | 2-(((4-Chloro-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-6-methoxy-1H-benzimidazole | C16H16ClN3O2S |
| 863031-21-4 | Azilsartan medoxomil;TAK 491; 1-((2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)(1,1'-biphenyl)-4-yl)methyl)-2-ethoxy-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester | C30H24N4O8 |
| 863031-24-7 | Azilsartan kamedoxomil;1-((2'-(2,5-Dihydro-5-oxo-1,2,4-oxadiazol-3-yl)(1,1'-biphenyl)-4-yl)methyl)-2-ethoxy-1H-benzimidazole-7-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester potassium salt | C30H23N4O8.K |
| 863032-29-5 | Methyl 4-pyrimidinylacetate | C7H8N2O2 |
| 863090-89-5 | 2,2,3,3,4,4-Hexafluoro-4-(trifluoromethoxy)butanoic acid | C5HF9O3 |
| 863111-48-2 | 2-Bromo-5-chloro-4-(trifluoromethyl)benzenamine | C7H4BrClF3N |
| 863118-41-6 | Methyl 6-(trifluoromethyl)-1-benzothiophene-2-carboxylate | C11H7F3O2S |
| 863127-76-8 | (E)-N-(2-Chloro-6-methylphenyl)-3-ethoxyacrylamide;(2E)-N-(2-Chloro-6-methylphenyl)-3-ethoxy-2-propenamide | C12H14ClNO2 |
| 863127-77-9 | Dasatinib monohydrate;N-(2-Chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-5-thiazolecarboxamide monohydrate | C22H26ClN7O2S.H2O |
| 863216-51-7 | 5-Amino-1H-benzimidazole-6-carboxylic acid | C8H7N3O2 |
| 863238-73-7 | 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-trityl-1H-pyrazole | C28H29BN2O2 |
| 863239-60-5 | Glyco Obeticholic Acid;3a,7a-dihydroxy-6a ethyl-5b-cholan-24-ol ; (3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-17-((R)-5-hydroxypentan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta(a)phenanthrene-3,7-diol | C28H47NO5 |
| 863239-61-6 | Obeticholic acid metabolite UPF-1443;Tauro-Obeticholic Acid;2-(((4R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta(a)phenanthren-17-yl)pentanoyl)amino)ethanesulfonic acid | C28H49NO6S |
| 863248-20-8 | 3-Morpholinophenylboronic acid hydrochloride;(3-(4-Morpholinyl)phenyl)boronic acid hydrochloride | C10H14BNO3.HCl |